Suggestions
Anula Jayasuriya
Co-Founder and Managing Director, Kidron Capital, Investors in Women's Health
Anula Jayasuriya is a highly accomplished venture capitalist and private equity executive with extensive experience in the healthcare and life sciences sectors.13 She holds multiple advanced degrees, including an MD and PhD in Microbiology and Molecular Genetics from Harvard Medical School, an MBA from Harvard Business School, and a M. Phil. in pharmacology from the University of Cambridge.13
Career Highlights
- Venture Partner at DigitalDx Ventures: Jayasuriya has been serving in this role since July 2022.5
- Founder of EXXclaim Capital: In 2013, she established this early-stage venture fund focused on women's health innovations.13
- Co-founder of Evolvence India Life Science Fund: In 2006, she co-founded this fund, which was the first to focus exclusively on healthcare investments in India.1
- Previous Roles: Partner at Skyline Ventures, German/US venture capital firm TVM, VP Business Development at Genomics Collaborative Inc., and Vice President of Global Drug Development at Hoffman-La Roche.13
Expertise and Focus
Jayasuriya is known for her unique combination of business acumen, scientific knowledge, and medical expertise.2 She has been a pioneer in recognizing the untapped opportunities in women's health, making strategic investments in this area.13 Her work spans various healthcare sectors, including digital health, medical devices, diagnostics, and consumer products.1
Recent Activities
As of February 2025, Jayasuriya remains active in the venture capital and healthcare innovation space. She recently participated in the HITLAB Digital Symposium in January 2025, discussing key investment insights from JPM 2025.4
Highlights
KIDRON Capital Assets Announces First Close of Women's Health VC Fund PR Newswire Tue, Apr 9, 2024, 12:00 AM PDT2 min read
Untapped Potential, Significant Returns: The first-of-its-kind fund with a presence in Israel, is led by expert female General Partners and targets untapped opportunities in Women's Health across Europe, the USA, and Israel. TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- We are thrilled to announce the successful first close of KIDRON Capital Assets, marking a significant milestone as the premier venture capital fund dedicated to Women's Health. Led by two female General Partners with profound investment and industry expertise in the HealthTech sector, KIDRON is uniquely positioned at the intersection of groundbreaking healthcare innovation and untapped investment potential. Our primary mission is to generate superb returns for our investors by capitalizing on the extensive, yet often overlooked, opportunities within the women's health sector.
Kidron Capital Assets Logo (PRNewsfoto/Kidron Capital Assets) Our investment reach extends across three key geographies—Europe, the USA, and Israel. KIDRON's portfolio encompasses a diverse array of sectors, including medical devices, diagnostics, digital health, therapeutics, and services. This strategic diversity ensures our ability to impact various facets of women's health while driving innovation, positive change, and outstanding returns for our investors.
Kkonnzz
